Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Chiron, Roche deal

CHIR (Emeryville, Calif.) and Hoffmann-La Roche will collaborate to market and co-promote Vitrasert,

Read the full 131 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE